Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | ACP3 | P15309 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MPI | P34949 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21802565 | 0.86 | ALDH1A1 (0.40) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 | |
| SCHEMBL2522149 | 0.82 | TSHR (0.44) | ALDH1A1CYP1A2KDM4ETSHRTDP1 | |
| SCHEMBL2127614 | 0.81 | ALDH1A1 (0.43) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 | |
| SCHEMBL7853160 | 0.79 | TAAR1 (0.48) | ALDH1A1CYP1A2CYP2A6HSD17B10KDM4E | |
| SCHEMBL10804024 | 0.79 | CYP1A2 (0.41) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 | |
| SCHEMBL29380144 | 0.78 | ALDH1A1 (0.44) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 | |
| SCHEMBL547819 | 0.78 | ALDH1A1 (0.44) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 | |
| SCHEMBL8955099 | 0.78 | KDM4E (0.38) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 | |
| SCHEMBL4818310 | 0.78 | KIF11 (0.48) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 | |
| SCHEMBL29972825 | 0.78 | KIF11 (0.48) | ALDH1A1CYP1A2CYP2A6ACP3HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-12630783-B2 | Muguet type fragrance compounds | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | SYMRISE AG (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-4045490-B1 | NEW AROMATIC MONOTHIOKETALS AS FRAGRANCES | SYMRISE AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-4624559-A2 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | Symrise AG (DE) | 2025-10-01 | — | — | EP | disclosed |
| EP-4006130-B1 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-3969163-B1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| EP-3924102-B1 | METHOD FOR PRODUCING MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| US-12103935-B2 | Seco-ambraketals | SYMRISE AG (DE) | 2024-10-01 | — | — | US | disclosed |
| EP-4428219-A2 | COMPOSITION FOR ODOUR IMPROVEMENT | Symrise AG (DE) | 2024-09-11 | — | — | EP | disclosed |
| EP-1310240-A1 | 6-Alkylindane-1-ones as perfuming agents | HAARMANN & REIMER GMBH (DE) | 2003-05-14 | — | — | EP | disclosed |
| EP-1285907-A2 | Compositions for the controlled release of an aldehyde together with two carboxylic acids | HAARMANN & REIMER GMBH (DE) | 2003-02-26 | — | — | EP | disclosed |
| EP-1285906-A2 | Compositions for the controlled release of an aldehyde or ketone, an alcohol and a carboxylic acid | HAARMANN & REIMER GMBH (DE) | 2003-02-26 | — | — | EP | disclosed |
| WO-2002076605-A1 | METHOD FOR PRODUCING ENCAPSULATIONS | SYMRISE GMBH & CO. KG (DE) | 2002-10-03 | — | — | WO | disclosed |
| EP-1220850-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2002-07-10 | — | — | EP | disclosed |
| EP-1215189-A1 | Process for the preparation of isolongifolanol | HAARMANN & REIMER GMBH (DE) | 2002-06-19 | — | — | EP | disclosed |
| EP-1111029-A2 | Perfume compositions containing 4,8-dimethyl-3,7-nonadien-2-one | HAARMANN & REIMER GMBH (DE) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001023373-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2001-04-05 | — | — | WO | disclosed |
| EP-1067126-A2 | Tetracyclic acetals | HAARMANN & REIMER GMBH (DE) | 2001-01-10 | — | — | EP | disclosed |
| EP-0273647-A1 | Coumaran derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1988-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | ALG3, FAAH, FAAH2 | ALDH1A1 53/4885CYP1A2 391/4885CYP2A6 809/4885 |
| US-12630783-B2 | Muguet type fragrance compounds | MGAT1, RFT1, CPT1A | ALDH1A1 132/4885CYP1A2 139/4885CYP2A6 262/4885 |
| US-12103935-B2 | Seco-ambraketals | AREG, CUTA, TAAR5 | ALDH1A1 1626/4885CYP1A2 504/4885CYP2A6 405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.